Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance - Fondation pour la Recherche Médicale Accéder directement au contenu
Article Dans Une Revue Communications Biology Année : 2023

Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance

Résumé

Bacterial antibiotic resistance is a global health concern of increasing importance and intensive study. Although biofilms are a common source of infections in clinical settings, little is known about the development of antibiotic resistance within biofilms. Here, we use experimental evolution to compare selection of resistance mutations in planktonic and biofilm Escherichia coli populations exposed to clinically relevant cycles of lethal treatment with the aminoglycoside amikacin. Consistently, mutations in sbmA , encoding an inner membrane peptide transporter, and fusA , encoding the essential elongation factor G, are rapidly selected in biofilms, but not in planktonic cells. This is due to a combination of enhanced mutation rate, increased adhesion capacity and protective biofilm-associated tolerance. These results show that the biofilm environment favors rapid evolution of resistance and provide new insights into the dynamic evolution of antibiotic resistance in biofilms.
Fichier principal
Vignette du fichier
s42003-023-04601-y.pdf (2.81 Mo) Télécharger le fichier
Origine : Publication financée par une institution
licence : CC BY - Paternité

Dates et versions

pasteur-04111698 , version 1 (31-05-2023)

Licence

Paternité

Identifiants

Citer

Masaru Usui, Yutaka Yoshii, Stanislas Thiriet-Rupert, Jean-Marc Ghigo, Christophe Beloin. Intermittent antibiotic treatment of bacterial biofilms favors the rapid evolution of resistance. Communications Biology, 2023, 6 (1), pp.275. ⟨10.1038/s42003-023-04601-y⟩. ⟨pasteur-04111698⟩
14 Consultations
49 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More